NasdaqGS - Nasdaq Real Time Price USD

Immunic, Inc. (IMUX)

Compare
1.0500
-0.0600
(-5.41%)
As of 12:21:03 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
98,052
98,052
99,223
86,518
91,665
Operating Income
-98,052
-98,052
-99,223
-86,518
-91,665
Net Non Operating Interest Income Expense
3,390
3,390
3,075
1,041
66
Other Income Expense
-5,845
-5,845
2,536
-34,930
-1,346
Pretax Income
-100,507
-100,507
-93,612
-120,407
-92,945
Net Income Common Stockholders
-100,507
-100,507
-93,612
-120,407
-92,945
Diluted NI Available to Com Stockholders
-100,507
-100,507
-93,612
-120,407
-92,945
Basic EPS
-1.00
-1.00
-2.11
-3.78
-3.93
Diluted EPS
-1.00
-1.00
-2.11
-3.78
-3.93
Basic Average Shares
100,174.7660
100,174.7660
44,320.0500
31,819.0060
23,652.7790
Diluted Average Shares
100,174.7660
100,174.7660
44,320.0500
31,819.0060
23,652.7790
Total Operating Income as Reported
-98,052
-98,052
-99,223
-119,488
-91,665
Total Expenses
98,052
98,052
99,223
86,518
91,665
Net Income from Continuing & Discontinued Operation
-100,507
-100,507
-93,612
-120,407
-92,945
Normalized Income
-95,711
-95,711
-93,612
-87,437
-92,945
Interest Income
3,390
3,390
3,075
1,041
66
Net Interest Income
3,390
3,390
3,075
1,041
66
EBIT
-98,052
-98,052
-99,223
-86,518
-91,665
EBITDA
-97,918
-97,918
-99,112
-86,441
-91,580
Reconciled Depreciation
134
134
111
77
85
Net Income from Continuing Operation Net Minority Interest
-100,507
-100,507
-93,612
-120,407
-92,945
Total Unusual Items Excluding Goodwill
-4,796
-4,796
--
-32,970
--
Total Unusual Items
-4,796
-4,796
--
-32,970
--
Normalized EBITDA
-93,122
-93,122
-99,112
-53,471
-91,580
12/31/2021 - 4/17/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CRDF Cardiff Oncology, Inc.
2.9350
-2.49%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.5479
-2.46%
 
UNCY Unicycive Therapeutics, Inc.
0.5702
+3.96%
 
URGN UroGen Pharma Ltd.
10.61
-5.31%
 
TERN Terns Pharmaceuticals, Inc.
2.4750
-0.60%
 
VSTM Verastem, Inc.
5.59
-4.28%
 
ABEO Abeona Therapeutics Inc.
4.7900
+2.35%
 
MRSN Mersana Therapeutics, Inc.
0.3262
-4.00%
 
IFRX InflaRx N.V.
1.0700
-6.96%
 
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.0349
0.00%